Literature DB >> 17179862

Mechanisms of glutamate receptor induced proliferation of astrocytes.

Srinivasan Kanumilli1, Peter J Roberts.   

Abstract

Astrocytes express mainly metabotropic glutamate receptor 3 and metabotropic glutamate receptor 5 receptor subtypes, which show opposing effects on cellular proliferation upon activation. In this study, we investigated the mechanisms by which activation of these receptors modulates astrocyte proliferation. Activation of metabotropic glutamate receptor 5 with (S)-3,5-dihydroxyphenylglycine increased phospholipase D activity in astrocytes as well as astrocyte proliferation. The 3,5-dihydroxyphenylglycine-induced proliferation was inhibited in the presence of the metabotropic glutamate receptor 5 antagonist (2-methyl-6-(phenylethynyl)pyridine), the protein kinase C inhibitor GF109203X, brefeldin A and 1-butanol. Activation of metabotropic glutamate receptor 3 with (2'S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)glycine-IV (DCG-IV) inhibited astrocyte proliferation without affecting metabotropic glutamate receptor 5-mediated phospholipase D activity. Metabotropic glutamate receptor 3 activation, however, only partially inhibited metabotropic glutamate receptor 5-mediated proliferation. In conclusion, metabotropic glutamate receptor 5 stimulates astrocyte proliferation via a protein kinase C-phospholipase D-phosphatidic acid-dependent pathway, whereas metabotropic glutamate receptor 3-mediated inhibition of astrocyte proliferation does not involve phospholipase D, and is independent of metabotropic glutamate receptor 5-mediated effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17179862     DOI: 10.1097/WNR.0b013e3280102ee6

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Transient mGlu5R inhibition enhances the survival of granule cell precursors in the neonatal cerebellum.

Authors:  C Kubera; A L Hernandez; V Heng; A Bordey
Journal:  Neuroscience       Date:  2012-06-04       Impact factor: 3.590

Review 2.  Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

Authors:  Rebecca F Budgett; Geor Bakker; Eugenia Sergeev; Kirstie A Bennett; Sophie J Bradley
Journal:  Front Pharmacol       Date:  2022-05-11       Impact factor: 5.988

3.  Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-kappaB.

Authors:  Raquel Sitcheran; William C Comb; Patricia C Cogswell; Albert S Baldwin
Journal:  Mol Cell Biol       Date:  2008-06-09       Impact factor: 4.272

4.  Glutamate release from astrocyte cell-line GL261 via alterations in the intracellular ion environment.

Authors:  Kenji Ono; Hiromi Suzuki; Madoka Higa; Kaori Tabata; Makoto Sawada
Journal:  J Neural Transm (Vienna)       Date:  2013-10-08       Impact factor: 3.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.